BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.18.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210304T120000
DTEND;TZID=America/New_York:20210304T130000
DTSTAMP:20210226T161901Z
CREATED:20210126T161411Z
LAST-MODIFIED:20210226T161901Z
UID:48672-1614859200-1614862800@globalbiodefense.com
SUMMARY:Integrating Inflammation and Coagulation in COVID-19
DESCRIPTION:The National Institutes of Health COVID-19 Scientific Interest Group will host a webcast on Integrating Inflammation and Coagulation in COVID-19 on March 4\, 2021. \nAbout the Speaker \nYogen Kanthi\, M.D.\, NHLBI Lasker Scholar\, NIH \nSpeaker Yogen Kanthi is a cardiologist and clinical vascular medicine specialist. His laboratory aims to understand how inflammation and coagulation contribute to vascular disease. He is interested in developing a deeper understanding of how innate immune circuits and communicate with coagulation and the vessel wall to license or restrict thrombosis. \nPlease visit the NIH VideoCast website for more information.
URL:https://globalbiodefense.com/event/integrating-inflammation-and-coagulation-in-covid-19/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:https://videocast.nih.gov/watch=41450
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210309T110000
DTEND;TZID=America/New_York:20210310T160000
DTSTAMP:20210226T160748Z
CREATED:20210126T154128Z
LAST-MODIFIED:20210226T160748Z
UID:48669-1615287600-1615392000@globalbiodefense.com
SUMMARY:Rapid Response by Laboratory Animal Research Institutions During the COVID-19 Pandemic
DESCRIPTION:The National Academies will host a committee meeting on Rapid Response by Laboratory Animal Research Institutions During the COVID-19 Pandemic: Lessons Learned from March 9-10\, 2021. \nRapid (and Precise) COVID-19 Vaccine Development\nBarney Graham\, M.D.\, Ph.D.\, Deputy Director\, Vaccine Research Center\, NIAID\, NIH \nThe COVID-19 Pandemic: The Triumphs and Challenges of Vaccine Development and Use of Animal Models in the Midst of a Pandemic\nIan Moore\, D.V.M.\, Ph.D.\, DACVP\, Investigative Veterinary Pathologist and Section Chief\, Infectious Disease\nPathogenesis Section\, NIAID\, NIH \nBringing Together Stakeholders: Users and Resources\nFranziska Grieder\, D.V.M.\, Ph.D.\, Director\, Office of Research Infrastructure Program\, Division of Program Coordination\, Planning\, and Strategic Initiatives\, NIH \nLessons Learned: NHP Supply\nKurt Derfler\, M.B.A.\, Executive Director of Operations\, Charles River Laboratories \nNonhuman Primate Importation During the SARS-CoV-2 Pandemic\nGale Galland\, D.V.M.\, M.S.\, DACVPM\, Veterinary Medical Officer\, Zoonoses Team\, Quarantine Border Health Services Branch\, Division of Global Migration and Quarantine\, CDC \nOccupational Health in a Pandemic\nMaureen Thompson\, BSN\, RN\, COHN\, RBP(ABSA)\, Safety Officer\, Yerkes National Primate Research Center\nAssociate Director\, Environmental Health and Safety Office\, Emory University \nRisk Assessment and Biosafety Support for SARS-CoV-2 and COVID-19 Research: Challenges in Established ABSL-2 and ABSL-3 Research Programs\nMolly Stitt-Fisher\, PhD\, CPH\, CBSP\, SM(NRCM)\, Rebecca Lingenfelter\, MSPH\, University Biosafety\, Officer/Associate Biosafety Officer and Alternate Responsible\, Official for Select Agents\, Department of Environmental Health and Safety\, University of Pittsburgh \nPublic Messaging and Communications About Animal-Based Research During the COVID-19 Pandemic\nJames O’Reilly\, B.A.\, President\, Massachusetts Society for Medical Research \nVirus Sequence Data During an Outbreak\nEneida Hatcher\, Ph.D.\, Contractor\, National Center for Biotechnology Information\, National Library of Medicine\,\nNIH \nThe Nonhuman Primate Model of SARS-CoV-2 to Test Therapeutic Strategies: Overcoming Challenges and Obstacles Towards Proof of Concept\nKoen Van Rompay\, D.V.M.\, Ph.D.\, Full Research Virologist\, California National Primate Research Center\nUC Davis \nFast Tracking Animal Model Development\, Collaborations\, and Research to Deliver Preclinical Data for Vaccine Antigen Selection\nIsis Kanevsky\, Ph.D.\, Director\, Vaccine Research Unit\, Pfizer \nManagement of a Nonhuman Primate Colony During SARS-CoV-2\nJoyce Cohen\, V.M.D.\, DACLAM\, Associate Director\, Division of Animal Resources\, Yerkes National Primate Research Center\, Emory University \nMaintaining Animal Research Continuity in the Time of COVID-19\nMichael J. Huerkamp\, D.V.M.\, DACLAM\nExecutive Director\, Division of Animal Resources\nEmory University \nResiliency in Animal Research Operations – COVID-19 Lessons Learned: Direct Staffing Impacts\nCDR Temeri Wilder-Kofie\, D.V.M.\, MPH\, DACLAM\, Facility Veterinarian\, Comparative Medicine Branch\, NIAID\, NIH \nResiliency in Animal Research Operations: Laboratory Animal Program Operations and Management Impacts\nJill Ascher\, M.A.\, D.V.M.\, MPH\, DACLAM\, Director\, Division of Veterinary Resources\, Office of Research Services\nNIH \nImpact of the COVID-19 Pandemic on Animal Research\nLori Palley\, D.V.M.\, DACLAM\, Assistant Director of Veterinary Services\, Center for Comparative Medicine\nMassachusetts General Hospital \nFinancial Impact of the COVID-19 Pandemic on Academic Animal Care Programs\nLucy Kennedy\, D.V.M.\, DACLAM\, Assistant Director for Clinical Services and Assistant Attending Veterinarian\, Unit for Laboratory Animal Medicine\, University of Michigan \nEvolving Prioritizations of In Vivo Research in Pharma During the COVID-19 Pandemic\nSean Maguire\, V.M.D.\, M.S.\, MRCVS\, DACLAM\, Comparative & Translational Sciences Director & Associate Fellow\, GlaxoSmithKline \nIntegrating the Institution’s COVID-19 Response Plan into the Research Animal Program\nStephen Denny\, D.V.M.\, M.S.\, DACLAM\, DACVPM\, Director\, Office of Animal Care and Use Office of Intramural Research\, NIH \nPanel Discussion – Resiliency in Animal Research Operations\nOpen panel discussion with audience participation \nPanelists: \n\nAcademia: Mike Huerkamp\, Lucy Kennedy\nGovernment: Jill Ascher\, Temeri Wilder-Kofie\, Stephen Denny\nIndustry – Pharma: Sean Maguire\nPrimate Research Center: Joyce Cohen\nAnimal Research Advocate: James O’Reilly\n\n\nMeeting Materials\n\n\n\nRapid Response Workshop Agenda\nSpeaker Abstracts\nSpeaker Biographies\n\n\nPlease visit the Rapid Response by Laboratory Animal Research Institutions During the COVID-19 Pandemic: Lessons Learned page for more information.
URL:https://globalbiodefense.com/event/rapid-response-by-laboratory-animal-research-institutions-during-the-covid-19-pandemic/
CATEGORIES:Webinar-Webcast,Workshop
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2021/02/rapid-response-animal-research-lab-covid-countermeasures-nasem.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20210330T160000
DTEND;TZID=America/New_York:20210330T180000
DTSTAMP:20210225T161411Z
CREATED:20210225T161411Z
LAST-MODIFIED:20210225T161411Z
UID:48631-1617120000-1617127200@globalbiodefense.com
SUMMARY:How COVID-19 Pandemic Changes Medical Research\, Teaching and Patient Care
DESCRIPTION:A virtual presentation on “How COVID-19 Pandemic Changes Medical Research\, Teaching and Patient Care” will be held on March 20\, 2021 as part of the 2021 Demystifying Medicine Series. \nThe 2021 Demystifying Medicine Series\, which is jointly sponsored by FAES and NIH\, will begin January 12 and includes the presentation of patients\, pathology\, diagnosis and therapy in the context of major disease problems and current research. Primarily directed toward Ph.D. students\, clinicians and program managers\, the course is designed to help bridge the gap between advances in biology and their application to major human diseases. Each session includes clinical and basic science components presented by NIH staff and invitees. All students\, fellows and staff are welcome\, as well. \nAbout the Speaker \nEzekiel J. Emanuel is the Vice Provost for Global Initiatives\, the Diane v.S. Levy and Robert M. Levy University Professor\, and Co-Director of the Healthcare Transformation Institute at the University of Pennsylvania. From January 2009 to January 2011\, Dr. Emanuel served as a Special Advisor on Health Policy to the Director of the Office of Management and Budget and National Economic Council. Prior to that he was the founding chair of the Department of Bioethics at the National Institutes of Health from 1997 to August of 2011. Dr. Emanuel received his M.D. from Harvard Medical School and his Ph.D. in political philosophy from Harvard University. After completing his internship and residency in internal medicine at Boston’s Beth Israel Hospital and his oncology fellowship at the Dana-Farber Cancer Institute\, he joined the faculty at the Dana-Farber Cancer Institute. He has since been a visiting professor at the University of Pittsburgh School of Medicine\, UCLA\, the Brin Professor at Johns Hopkins Medical School\, and the Kovitz Professor at Stanford Medical School and visiting professor at New York University Law School. Dr. Emanuel served on President Clinton’s Health Care Task Force\, the National Bioethics Advisory Commission (NBAC)\, and on the bioethics panel of the Pan-American Healthcare Organization. He has published over 300 articles mainly on health care reform\, research ethics\, and end of life care. He has also authored or edited 15 books. \nPlease visit the NIH Demystifying Medicine website for more information.
URL:https://globalbiodefense.com/event/how-covid-19-pandemic-changes-medical-research-teaching-and-patient-care/
CATEGORIES:Government Hosted,Webinar-Webcast,Workshop
LOCATION:https://videocast.nih.gov/watch=41575
END:VEVENT
END:VCALENDAR